Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients

Journal of the Neurological Sciences

Volumn 220, Issue 1-2, 2004, Pages 41-48

  Winkler Stuck, Kirstin ^a   Wiedemann, Falk R ^a   Wallesch, Claus W ^a   Kunz, Wolfram S ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Coenzyme Q 10; Coenzyme Q10; CoQ10; Fibroblasts; Mitochondria; Oxidative phosphorylation; Parkinson's disease; PD; Unified Parkinson's Disease Rating Scale; UPDRS

Indexed keywords

ANTIOXIDANT; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE; ADENOSINE DIPHOSPHATE; AMOBARBITAL; DRUG DERIVATIVE; GLUTAMIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXYGEN; PYRUVIC ACID; UBIQUINONE;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MALE; MICROANALYSIS; MITOCHONDRIAL RESPIRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SKIN FIBROBLAST; TITRIMETRY; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; FIBROBLAST; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; SKIN;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AMOBARBITAL; ANTIOXIDANTS; CELLS, CULTURED; DRUG INTERACTIONS; FEMALE; FIBROBLASTS; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NAD; OXYGEN; PARKINSON DISEASE; PYRUVIC ACID; SKIN; UBIQUINONE;

EID: 2442497176     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.02.003     Document Type: Article

References (47)

1. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54(3):1990;823-827
2. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H., Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain. 115(Pt. 2):1992;333-342
3. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163(3):1989;1450-1455
4. Hattori N., Tanaka M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30(4):1991;563-571
5. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219(4587):1983;979-980
6. Nicklas W.J., Vyas I., Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. Life Sci. 36(26):1985;2503-2508
7. Vyas I., Heikkila R.E., Nicklas W.J. Studies on the neurotoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. J. Neurochem. 46(5):1986;1501-1507
8. Nakagawa-Hattori Y., Yoshino H., Kondo T., Mizuno Y., Horai S. Is Parkinson's disease a mitochondrial disorder? J. Neurol. Sci. 107(1):1992;29-33
9. Mizuno Y., Ikebe S., Hattori N., Nakagawa-Hattori Y., Mochizuki H., Tanaka M., et al. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim. Biophys. Acta. 1271(1):1995;265-274
10. Gu M., Cooper J.M., Taanman J.W., Schapira A.H. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44(2):1998;177-186
11. Swerdlow R.H., Parks J.K., Davis J.N., Cassarino D.S., Trimmer P.A., Currie L.J., et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44(6):1998;873-881
12. Bindoff L.A., Birch-Machin M.A., Cartlidge N.E., Parker W.D. Jr., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104(2):1991;203-208
13. Shoffner J.M., Watts R.L., Juncos J.L., Torroni A., Wallace D.C. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30(3):1991;332-339
14. Cardellach F., Marti M.J., Fernandez-Sola J., Marin C., Hoek J.B., Tolosa E., et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology. 43(11):1993;2258-2262
15. Blin O., Desnuelle C., Rascol O., Borg M., Peyro Saint P.H., Azulay J.P., et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J. Neurol. Sci. 125(1):1994;95-101
16. Anderson J.J., Bravi D., Ferrari R., Davis T.L., Baronti F., Chase T.N., et al. No evidence for altered muscle mitochondrial function in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 56(5):1993;477-480
17. Di Monte D.A., Sandy M.S., Jewell S.A., Langston J.W. Oxidative phosphorylation by intact muscle mitochondria in Parkinson's disease. Neurodegeneration. 2(4):1993;275-281
18. DiDonato S., Zeviani M., Giovannini P., Savarese N., Rimoldi M., Mariotti C., et al. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology. 43(11):1993;2262-2268
19. Reichmann H., Janetzky B., Bischof F., Seibel P., Schols L., Kuhn W., et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur. Neurol. 34(5):1994;263-267
20. Taylor D.J., Krige D., Barnes P.R., Kemp G.J., Carroll M.T., Mann V.M., et al. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease. J. Neurol. Sci. 125(1):1994;77-81
21. Parker W.D. Jr., Boyson S.J., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26(6):1989;719-723
22. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., Schapira A.H. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 32(6):1992;782-788
23. Yoshino H., Nakagawa-Hattori Y., Kondo T., Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J. Neural Transm., Parkinson's Dis. Dement. Sect. 4(1):1992;27-34
24. Benecke R., Strumper P., Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain. 116(Pt. 6):1993;1451-1463
25. Haas R.H., Nasirian F., Nakano K., Ward D., Pay M., Hill R., et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37(6):1995;714-722
26. Bravi D., Anderson J.J., Dagani F., Davis T.L., Ferrari R., Gillespie M., et al. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov. Disord. 7(3):1992;228-231
27. Blake C.I., Spitz E., Leehey M., Hoffer B.J., Boyson S.J. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov. Disord. 12(1):1997;3-8
28. Schapira A.H., Cooper J.M. Mitochondrial function in neurodegeneration and ageing. Mutat. Res. 275(3-6):1992;133-143
29. Singer T.P., Ramsay R.R., Ackrell B.A. Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies. Biochim. Biophys. Acta. 1271(1):1995;211-219
30. Wiedemann F.R., Winkler K., Lins H., Wallesch C.W., Kunz W.S. Detection of respiratory chain defects in cultivated skin fibroblasts and skeletal muscle of patients with Parkinson's disease. Ann. N. Y. Acad. Sci. 893:1999;426-429
31. 10 in Parkinson's disease. J. Neural. Transm. 107(1):2000;41-48
32. 10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 42(2):1997;261-264
33. 10 attenuates the 1-methyl-4-phenyl-1, 2, 3, tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 783(1):1998;109-114
34. 10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59(10):2002;1541-1550
35. Maker H.S., Weiss C., Silides D.J., Cohen G. Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36(2):1981;589-593
36. Berman S.B., Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73(3):1999;1127-1137
37. Kunz D., Luley C., Fritz S., Bohnensack R., Winkler K., Kunz W.S., et al. Oxygraphic evaluation of mitochondrial function in digitonin-permeabilized mononuclear cells and cultured skin fibroblasts of patients with chronic progressive external ophthalmoplegia. Biochem. Mol. Med. 54(2):1995;105-111
38. Kuznetsov A.V., Winkler K., Kirches E., Lins H., Feistner H., Kunz W.S. Application of inhibitor titrations for the detection of oxidative phosphorylation defects in saponin-skinned muscle fibers of patients with mitochondrial diseases. Biochim. Biophys. Acta. 1360(2):1997;142-150
39. Kuznetsov A.V., Clark J.F., Winkler K., Kunz W.S. Increase of flux control of cytochrome c oxidase in copper-deficient mottled brindled mice. J. Biol. Chem. 271(1):1996;283-288
40. Li W., Palmer G. Spectroscopic characterization of the interaction of azide and thiocyanate with the binuclear center of cytochrome oxidase: evidence for multiple ligand sites. Biochemistry. 32(7):1993;1833-1843
41. Wiedemann F.R., Winkler K., Kuznetsov A.V., Bartels C., Vielhaber S., Feistner H., et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 156(1):1998;65-72
42. Kunz W.S. Control of oxidative phosphorylation in skeletal muscle. Biochim. Biophys. Acta. 1504(1):2001;12-19
43. Villani G., Greco M., Papa S., Attardi G. Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J. Biol. Chem. 273(48):1998;31829-31836
44. Bergmeier H.U. Citratsyntase. Bergmeier H.U. Methoden der enzymatischen Analyse. 1974;727-733 Wissenschaftsverlag, Weinheim/Bergstrasse
45. Rustin P., Parfait B., Chretien D., Bourgeron T., Djouadi F., Bastin J., et al. Fluxes of nicotinamide adenine dinucleotides through mitochondrial membranes in human cultured cells. J. Biol. Chem. 271(25):1996;14785-14790
46. Chretien D., Benit P., Chol M., Lebon S., Rotig A., Munnich A., et al. Assay of mitochondrial respiratory chain complex I in human lymphocytes and cultured skin fibroblasts. Biochem. Biophys. Res. Commun. 301(1):2003;222-224
47. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta. 1271(1):1995;195-204